SANTA ANA, Calif.--(BUSINESS
WIRE)--Oct. 1, 2002--Pro-Dex, Inc.
PDEX today announced financial results for the
fiscal year ending June 30, 2002. Net income (loss) for
the year was ($1,566,000) or ($0.18) per share compared
to $2,847,000 or $0.32 per share for the year ended June
30, 2001. The Company incurred a loss from continuing
operations of ($1,165,000) or ($0.13) per share for the
year ended June 30, 2002 compared to a (loss) from
continuing operations of ($1,297,000) or ($0.15) per
share for the previous year. Loss from discontinued
operations for the year ended June 30, 2002 is
($401,000) or ($0.05) per share compared to income of
$4,144,000 or $0.47 per share for the year ended June
30, 2001.
Commenting on the Company's financial performance,
Pro-Dex's newly appointed President and CEO, Patrick
Johnson, said, "Given the tremendous progress we've made
in restructuring the Company in the past year, it's
disappointing to report poor financial results.
Particularly given the dramatic turn-around this past
year at Micro Motors, we'd hoped that the consolidated
financial results would better demonstrate the
significant strides we have made in repositioning the
Company and returning it to profitability. The
divestiture of our Biotrol and Challenge subsidiaries at
the close of fiscal year 2001 had a substantial
favorable impact on our financial performance for that
year. Conversely, we were unfavaorably impacted in
fiscal 2002 by the same transactions, making it a
challenge to see the true performance of the Company as
it moves forward. Despite the unfavorable financial
results we are reporting today, we are confident that we
have made the right decisions in restructuring the
company, decisions that will begin to prove themselves
as we move into fiscal 2003."
Consolidated net sales decreased 29% to $10.5 million
for the year ended June 30, 2002 from $14.8 million in
the year ended June 30, 2001. The sales decline was
primarily due to the decrease in sales at the Company's
OMS subsidiary, reflecting continued slowness in the
semiconductor fabrication industry.
At the Company's Micro Motor subsidiary, sales for
the year ended June 30, 2002 increased 7% from the year
ended June 30, 2001. Sales increased in all of Micro
Motors' standard product lines, realizing the benefit of
the investment it has made in the design and development
of powered rotary drive systems for use in the medical
market and increases in its core dental business.
Regarding Micro Motor's sales, Mr. Johnson noted, "We've
not focused just on increasing sales . . . . we've
focused on increasing profitable sales. This has meant
developing new products and new customer relationships,
re-defining existing customer relationships and
aggressively re-structuring our pricing models."
Sales at OMS decreased 68% from the previous year.
The decline was a result of the continued slowdown in
the electronics and semiconductor industry that began in
November 2000. Commenting on OMS's reduced sales, Mr.
Johnson stated, "OMS continues to develop a business
strategy to reduce its exposure to the cycles of the
semiconductor equipment manufacture industry. Included
in that strategy is the development of a new family of
embedded motion control products based on the PowerPC(R)
power chip and expansion into new markets."
Consolidated gross profit decreased 39% from $6.8
million to $4.1 million for the year ended June 30, 2002
compared to the year ended June 30, 2001. The sharp
decrease in gross profit was directly related to the
decrease in sales at OMS. Gross profit margin at OMS
also decreased given the cost of excess fixed cost
capacity due to lower revenue and increased reserves for
slow moving inventory. "OMS worked all year to
'right-size' its operations in relation to the
diminished sales level, tracking at a profitable rate of
performance as it exited the fiscal year," stated Mr.
Johnson. Gross profit and gross profit margins at Micro
Motors however improved dramatically as the result of
more efficient manufacturing practices, better inventory
control, reduced building rental costs and favorable
pricing on recently developed products.
During the year, the Company reduced its operating
expenses 9% from $6,236,000 for the year ended June 30,
2002 compared to $6,839,000 for the year ended June 30,
2001 (excluding unusual non-recurring charge incurred in
fiscal year 2001). Micro Motors has dramatically
consolidated its operations and reduced the expenses
related to those operations, while continuing to grow
overall sales and develop new products. This resulted in
an operating expense reduction of $306,000 or nearly
12%. OMS also drastically reduced its number of
employees, made deep cuts in sales and marketing
expenses and focused on maximizing the sales of existing
product to existing customers. These efforts resulted in
an operational expense savings of $389,000 or 15%,
despite OMS's accelerated development activities related
to their new PowerPC(R) based motion control products.
Mr. Johnson also noted, "Operational expense related to
corporate activities remained flat at $1,808,000, but
based on structural changes made late in the year,
corporate expenses should decrease by more than $1
million in fiscal year 2003."
Commenting on the Company's on-going operations, Mr.
Johnson noted, "We incurred several non-recurring
significant expenses during the year that directly
impacted our operational profitability, expenses that we
will not have in fiscal year 2003. Specifically, OMS had
amortization expenses of $404,000 last year related to
patents. This expense item we anticipate will only be
$32,000 in fiscal year 2003. In addition, given changes
in accounting regulations, we expensed all of the
goodwill remaining on OMS's books, incurring a one-time
charge of $154,000, another expense we will not incur in
fiscal year 2003. We also don't anticipate any further
impact from the Biotrol and Challenge divestitures,
transactions that resulted in $668,000 in unfavorable
expenses to the Company during the year from
discontinued operations."
Addressing the near future of the Company, Mr.
Johnson said, "Fiscal year 2002 was a significant
transitional year for Pro-Dex. We moved our corporate
operations to California following the sale of Biotrol
and Challenge and brought to closure all the open issues
related to that sale. We downsized the operations of
both Micro Motors and OMS, while we continued to focus
on developing new products, new markets and new
customers. . . . all of this with an eye to increasing
the profitability of the Company. We successfully
established a new banking relationship with Wells Fargo,
including a $3 million credit facility. We entered into
several new development contracts that should lead to
increased sales through exclusive manufacturing
agreements. We are on the threshold of a new era for
Pro-Dex and we are very excited about where we have
positioned the Company. We are confident our
stockholders will share that feeling as we work to
produce healthy operating results during this current
fiscal year and beyond."
Pro-Dex, Inc., is a California-based holding company
with the following wholly-owned operating subsidiaries:
Micro Motors, Inc., located in Santa Ana, California,
manufactures miniature electric, pneumatic and battery
powered rotary drive systems for use in the high tech
medical, dental and industrial industries; and Oregon
Micro Systems, Inc., located in Beaverton, Oregon,
manufactures motion control products used in factory
automation and the semiconductor industries.
For more information, visit the Company's website at
www.pro-dex.com.
Statements herein concerning the Company's plans,
growth and strategies may include 'forward-looking
statements' within the context of the federal securities
laws. Statements regarding the Company's future events,
developments and future performance, as well as
management's expectations, beliefs, plans, estimates or
projections relating to the future, are forward-looking
statements within the meaning of these laws. The
Company's actual results may differ materially from
those suggested as a result of various factors.
Interested parties should refer to the disclosure
concerning the operational and business concerns of the
Company set forth in the Company's filings with the
Securities and Exchange Commission.